TREATMENT OF CDKL5 DISORDERS WITH GSK3 BETA INHIBITOR TIDEGLUSIB

Patent title TREATMENT OF CDKL5 DISORDERS WITH GSK3 BETA INHIBITOR TIDEGLUSIB
Thematic area Health
Ownership ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA
Inventors Elisabetta Ciani, Claudia Fuchs
Filed on 10 March 2016
Page published on: 12 October 2018